Interview Questions152

    The Services PE Playbook: Rollover Equity and Value Creation

    Rollover equity (~75% cash + ~25% rolled), the second bite at exit, and operational levers: RCM centralization, payer renegotiation, procurement, de novo expansion.

    |
    6 min read
    |
    2 interview questions
    |

    Introduction

    Beyond multiple arbitrage, healthcare services PE firms create value through a well-defined operational playbook. The firms that consistently generate top-quartile returns are those that combine disciplined add-on execution with genuine operational improvement, growing EBITDA per location rather than relying solely on adding more locations. Healthcare bankers advising on PE transactions must understand both the financial structure (rollover equity, leverage) and the operational thesis (value creation levers) to effectively position sell-side opportunities and evaluate buy-side opportunities.

    Rollover Equity

    Rollover Equity

    The portion of a seller's proceeds that is reinvested (rolled over) into equity in the new PE-backed entity rather than taken as cash. In a typical healthcare services transaction, the seller receives approximately 70-85% of the purchase price in cash and reinvests 15-35% as equity in the new platform. The rolled equity gives the seller ownership in the combined entity, aligning their interests with post-acquisition performance and providing the opportunity for a "second bite at the apple" when the PE firm exits.

    Rollover equity serves multiple purposes in healthcare services transactions:

    Physician alignment. In physician practice management, rollover equity keeps the selling physician financially motivated to continue practicing, referring patients, and supporting the platform's growth. Without rollover, physicians may disengage post-acquisition, causing patient and revenue attrition.

    Tax efficiency. Rollover equity can defer capital gains taxes on the reinvested portion, effectively allowing the seller to invest pre-tax dollars in the combined entity's growth.

    Return amplification. If the platform's value doubles by the next PE exit (3-5 years later), the rolled equity doubles as well. A physician who rolled $2M of a $10M sale could receive $4M on the second exit, earning more total consideration than if they had taken 100% cash at the first sale.

    The Value Creation Levers

    Revenue Cycle Management Centralization

    The single largest and most repeatable value creation lever in healthcare services. Small independent practices typically leave 5-15% of revenue on the table through coding errors, missed charges, slow claim submission, inadequate denial management, and poor patient collections.

    Centralizing RCM onto a professional platform with dedicated coders, automated claim scrubbing, systematic denial follow-up, and patient payment optimization can recover a substantial portion of this leakage within 6-12 months of integration.

    Payer Contract Renegotiation

    Scale enables better payer contract terms. A single-physician practice has essentially zero negotiating leverage with commercial payers: the payer can drop the practice from its network without meaningful patient disruption. A 200-physician platform covering a metropolitan area has significant leverage because the payer cannot drop the entire network without creating patient access problems.

    Typical payer rate improvements post-consolidation range from 5-20%, with the largest increases in markets where the platform achieves sufficient density to be "must-have" for payer network adequacy.

    Procurement Optimization

    Group purchasing across multiple locations reduces costs for supplies, equipment, technology, and services. Savings of 5-15% on supply costs are typical, with the largest savings in categories with high spend variability (dental supplies, medical/surgical supplies, lab services).

    De Novo Expansion

    Opening new locations organically (de novo) rather than through acquisition avoids paying acquisition premiums. De novo locations cost $200K-$1M to open (depending on the sub-sector) and typically reach breakeven within 12-18 months. The trade-off is slower initial ramp (no existing patient base) and execution risk (site selection, hiring, marketing). The best platforms combine add-on acquisitions (immediate EBITDA) with de novo expansion (no acquisition premium, purpose-built locations).

    Provider Productivity Improvement

    Optimizing scheduling, support staffing, and clinical workflows to increase provider productivity (patients per day, wRVUs per provider, revenue per provider). Even modest productivity improvements (one additional patient per provider per day) compound across dozens or hundreds of providers to create significant revenue uplift. Specific initiatives include reducing patient no-shows through automated reminders and overbooking protocols, adding scribes and medical assistants so providers spend more time on patient-facing activities, optimizing scheduling templates to reduce gaps between appointments, and implementing telehealth for appropriate visit types (follow-ups, medication checks) to increase daily volume without additional facility space.

    The next article covers analyzing healthcare services financials, including NPR waterfalls, EBITDA normalization, and the KPIs that define each sub-sector.

    Interview Questions

    2
    Interview Question #1Medium

    What are the key value creation levers for PE in healthcare services?

    PE creates value through five primary levers:

    1. Revenue growth. Organic growth from new patient acquisition, geographic expansion, provider recruitment, and ancillary service additions (lab, imaging, therapy). Inorganic growth through add-on acquisitions.

    2. Margin expansion. Centralize billing and collections (improving collection rates from 85-90% to 95%+), consolidate procurement (volume discounts on supplies), reduce overhead through shared services, and optimize staffing.

    3. Multiple arbitrage. Buy small practices at 5-7x EBITDA, grow the platform, and exit at 10-14x. Scale is the single largest driver of multiple expansion in healthcare services.

    4. Payer optimization. Renegotiate commercial payer contracts at scale (larger networks command higher reimbursement rates). Improve payer mix by expanding into commercial-heavy geographies.

    5. De novo growth. Open new locations in underserved markets, which can be more cost-effective than acquisitions once the platform has the infrastructure to support greenfield expansion.

    The strongest returns combine all five levers. A platform that grows EBITDA through acquisitions AND organic growth AND margin expansion, then exits at a higher multiple with leverage, can generate equity returns of 3-5x MoIC.

    Interview Question #2Medium

    What is rollover equity and why is it important in physician practice transactions?

    Rollover equity is the portion of a seller's proceeds that is reinvested ("rolled over") into equity in the acquiring entity (the MSO or holdco) rather than taken as cash at closing. In physician practice transactions, sellers typically roll 20-40% of their equity value.

    Why it is important:

    1. Alignment of interests. Physicians who roll equity are incentivized to continue growing the practice because they will benefit from the platform's value appreciation at the PE firm's future exit. Without skin in the game, physicians may disengage post-acquisition.

    2. Retention mechanism. Rollover equity, combined with employment agreements and non-competes, keeps key physicians committed to the platform during the hold period. Physician attrition is the single biggest risk in healthcare services PE.

    3. "Second bite of the apple." Physicians receive liquidity at closing (60-80% of value) and then participate in the platform's value creation. If the PE firm achieves a 2.5-3x MoIC, the rollover equity can be worth more than the original cash proceeds.

    4. Regulatory compliance. In CPOM states, rollover equity helps maintain the physician ownership requirement for the PC. The friendly physician who owns the PC typically has meaningful rollover equity aligning their interests.

    5. Capital efficiency. Rollover reduces the total cash the PE firm must deploy upfront, improving return metrics.

    Explore More

    Restructuring Investment Banking: What Makes It Different

    Explore restructuring investment banking (RX) and what distinguishes it from traditional coverage groups. Learn about the work, skills required, recruiting, and why RX experiences countercyclical demand.

    December 26, 2025

    How to Answer "Walk Me Through a Deal You Followed"

    Master one of the most common IB interview questions. Learn how to discuss M&A deals intelligently with frameworks, what details matter, and how to demonstrate market awareness.

    September 23, 2025

    Common Valuation Multiples Explained

    Learn the most common valuation multiples in investment banking, including EV/EBITDA, P/E, EV/Revenue, and how to use them in practice.

    August 1, 2025

    Ready to Transform Your Interview Prep?

    Join 3,000+ students preparing smarter

    Join 3,000+ students who have downloaded this resource